0001683168-20-000786.txt : 20200312 0001683168-20-000786.hdr.sgml : 20200312 20200312183919 ACCESSION NUMBER: 0001683168-20-000786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200312 DATE AS OF CHANGE: 20200312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IWAKI YUICHI CENTRAL INDEX KEY: 0001263965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33185 FILM NUMBER: 20710219 MAIL ADDRESS: STREET 1: C/O MEDICINOVA, INC. STREET 2: 4275 EXECUTIVE SQUARE, SUITE 650 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINOVA INC CENTRAL INDEX KEY: 0001226616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330927979 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-373-1500 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2020-03-12 0 0001226616 MEDICINOVA INC MNOV 0001263965 IWAKI YUICHI C/O MEDICINOVA, INC. 4275 EXECUTIVE SQUARE, SUITE 300 LA JOLLA CA 92037 1 1 0 0 President and CEO Common Stock 2020-03-12 4 P 0 20000 3.10 A 780683 D Common Stock 125000 I See Footnote The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price at price ranging from $3.055 to $3.14. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Includes 1,291shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). The reported securities are held by the Iwaki Family Limited Partnership. The reporting person is the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ Yuichi Iwaki 2020-03-12